Screening for Breast Cancer – Clinical Guidelines

Overview
Start Module

Featured Article

US. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Task Force recommendation statement. Ann Int Med 2009;151:716-26

Expert Reviews:

Methodological Reviewer
Steve Latosinsky MD, MSc, FRCSC, Department of Surgery, University of Western Ontario

Clinical Reviewer
Ralph George MD FRCSC, Department of Surgery, University of Toronto

Clinical Reviewer
Hiram Cody III MD, FACS, Department of Surgery, Memorial Sloan-Kettering Cancer Center

Supplementary Articles

Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. How to Use Clinical Practice Guidelines (A). JAMA 1995;274(7):570-74

Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt G, for the Evidence-Based Medicine Working Group. Users’ Guides to the Medical Literature. How to Use Clinical Practice Guidelines (B). JAMA 1995;274(20):1630-32

Questions

Please read the provided articles and be prepared to discuss the following:

  1. What are the clinical questions being asked?
  2. Were all important options and outcomes considered?
  3. Was an explicit and sensible process used to identify, select and combine evidence?
  4. Was an explicit and sensible process used to consider the relative value of different outcomes?
  5. Is the guideline likely to account for important recent developments?
  6. Has the guideline been subjected to peer review and testing?
  7. Are practical clinically important recommendations made?
  8. How strong are the recommendations?
  9. What is the impact of uncertainty associated with the evidence and values used in the guidelines?
  10. State the conclusion. Have the authors addressed the clinical questions posed?
  11. Does the evidence support the conclusion?
Start Module